Search

everythinglearnresearchcommunity

for

Search:↓

Insulin changes sex hormone levels in women with polycystic ovary syndrome without affecting other hormone releases.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Ovarian steroid cell tumors can mimic adrenal hyperplasia, and surgery can normalize hormone levels.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Women with PCOS often have different clinical signs, hormone levels, and gynecological issues compared to those without the condition.

Ovarian stromal volume doesn't relate to PCOS biochemical indices.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

A woman's symptoms of increased body hair and testosterone were caused by a rare adrenal tumor, which was removed successfully.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

FOXA1 and CCL2 genes are more active in women with PCOS, varying by phenotype.

A 20-year-old woman was found to have a rare ovarian tumor causing symptoms like acne and a low-pitched voice, which disappeared after the tumor was removed.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

New ultrasound criteria for diagnosing PCOS in North African patients were successfully established.

Hyperandrogenism and insulin resistance in PCOS-like rats can lead to pregnancy complications due to increased cell death in the uterus and placenta.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

Certain gene variations are found in people with polycystic ovary syndrome.

A postmenopausal woman's excess male hormone symptoms were caused by a rare adrenal gland tissue in her ovary.

11-oxyandrogens are linked to excess hair growth in PCOS, but don't help diagnose it.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Women with PCOS have hormonal imbalances and increased central obesity, highlighting the need for early detection and management.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.